Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules
15 janv. 2015 10h46 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine
24 mars 2014 08h00 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that on March 21, 2014, the Company filed a Changes Being...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
18 févr. 2014 07h00 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today successful results from a pilot bioequivalence study...